Health-related quality of life in patients receiving first-line eribulin mesylate with or without trastuzumab for locally recurrent or metastatic breast cancer

Overview of attention for article published in BMC Cancer, June 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

peer_reviews: 1 peer review site

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 88 Mendeley

Summary Peer reviews Dimensions citations

So far, Altmetric has seen 1 peer review site that discusses this research output.

Publons

This paper has 1 review on Publons, an academic research evaluation site.

Review by Professor Dr. Sorush Niknamian

17 Jun 2019